Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Cognitive enhancement therapy improves emotional intelligence in early course schizophrenia: preliminary effects.

Eack SM, Hogarty GE, Greenwald DP, Hogarty SS, Keshavan MS.

Schizophr Res. 2007 Jan;89(1-3):308-11. Epub 2006 Oct 19.

2.

Mechanisms of functional improvement in a 2-year trial of cognitive enhancement therapy for early schizophrenia.

Eack SM, Pogue-Geile MF, Greenwald DP, Hogarty SS, Keshavan MS.

Psychol Med. 2011 Jun;41(6):1253-61. doi: 10.1017/S0033291710001765. Epub 2010 Sep 22.

3.

Assessing social-cognitive deficits in schizophrenia with the Mayer-Salovey-Caruso Emotional Intelligence Test.

Eack SM, Greeno CG, Pogue-Geile MF, Newhill CE, Hogarty GE, Keshavan MS.

Schizophr Bull. 2010 Mar;36(2):370-80. doi: 10.1093/schbul/sbn091. Epub 2008 Jul 22.

4.

Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.

Hogarty GE, Flesher S, Ulrich R, Carter M, Greenwald D, Pogue-Geile M, Kechavan M, Cooley S, DiBarry AL, Garrett A, Parepally H, Zoretich R.

Arch Gen Psychiatry. 2004 Sep;61(9):866-76.

PMID:
15351765
5.

Negative symptom improvement during cognitive rehabilitation: results from a 2-year trial of Cognitive Enhancement Therapy.

Eack SM, Mesholam-Gately RI, Greenwald DP, Hogarty SS, Keshavan MS.

Psychiatry Res. 2013 Aug 30;209(1):21-6. doi: 10.1016/j.psychres.2013.03.020. Epub 2013 Apr 23.

6.

A new computerized cognitive and social cognition training specifically designed for patients with schizophrenia/schizoaffective disorder in early stages of illness: A pilot study.

Fernandez-Gonzalo S, Turon M, Jodar M, Pousa E, Hernandez Rambla C, GarcĂ­a R, Palao D.

Psychiatry Res. 2015 Aug 30;228(3):501-9. doi: 10.1016/j.psychres.2015.06.007. Epub 2015 Jun 18.

PMID:
26163731
7.

Is cognitive enhancement therapy equally effective for patients with schizophrenia and schizoaffective disorder?

Lewandowski KE, Eack SM, Hogarty SS, Greenwald DP, Keshavan MS.

Schizophr Res. 2011 Feb;125(2-3):291-4. doi: 10.1016/j.schres.2010.11.017. Epub 2010 Dec 17.

PMID:
21167689
8.

Durability and mechanism of effects of cognitive enhancement therapy.

Hogarty GE, Greenwald DP, Eack SM.

Psychiatr Serv. 2006 Dec;57(12):1751-7.

PMID:
17158490
9.

Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial.

Eack SM, Hogarty GE, Cho RY, Prasad KM, Greenwald DP, Hogarty SS, Keshavan MS.

Arch Gen Psychiatry. 2010 Jul;67(7):674-82. doi: 10.1001/archgenpsychiatry.2010.63. Epub 2010 May 3.

10.

A broad cortical reserve accelerates response to cognitive enhancement therapy in early course schizophrenia.

Keshavan MS, Eack SM, Wojtalik JA, Prasad KM, Francis AN, Bhojraj TS, Greenwald DP, Hogarty SS.

Schizophr Res. 2011 Aug;130(1-3):123-9. doi: 10.1016/j.schres.2011.05.001. Epub 2011 Jun 8.

11.

Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial.

Keefe RS, Vinogradov S, Medalia A, Buckley PF, Caroff SN, D'Souza DC, Harvey PD, Graham KA, Hamer RM, Marder SM, Miller DD, Olson SJ, Patel JK, Velligan D, Walker TM, Haim AJ, Stroup TS.

J Clin Psychiatry. 2012 Jul;73(7):1016-22. doi: 10.4088/JCP.11m07100. Epub 2012 May 15.

12.

Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18-month feasibility trial.

Eack SM, Hogarty SS, Greenwald DP, Litschge MY, McKnight SA, Bangalore SS, Pogue-Geile MF, Keshavan MS, Cornelius JR.

Schizophr Res. 2015 Feb;161(2-3):478-83. doi: 10.1016/j.schres.2014.11.017. Epub 2014 Dec 12.

13.

Structural neurobiological correlates of Mayer-Salovery-Caruso Emotional Intelligence Test performance in early course schizophrenia.

Wojtalik JA, Eack SM, Keshavan MS.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:207-12. doi: 10.1016/j.pnpbp.2012.09.013. Epub 2012 Oct 2.

14.

Traditional Chinese version of the Mayer Salovey Caruso Emotional Intelligence Test (MSCEIT-TC): Its validation and application to schizophrenic individuals.

Mao WC, Chen LF, Chi CH, Lin CH, Kao YC, Hsu WY, Lane HY, Hsieh JC.

Psychiatry Res. 2016 Sep 30;243:61-70. doi: 10.1016/j.psychres.2016.04.107. Epub 2016 Jun 21.

PMID:
27367492
15.

Neurocognitive and social cognitive predictors of interpersonal skill in schizophrenia.

Pinkham AE, Penn DL.

Psychiatry Res. 2006 Aug 30;143(2-3):167-78. Epub 2006 Jul 21.

PMID:
16859754
16.

Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial.

Eack SM, Greenwald DP, Hogarty SS, Cooley SJ, DiBarry AL, Montrose DM, Keshavan MS.

Psychiatr Serv. 2009 Nov;60(11):1468-76. doi: 10.1176/appi.ps.60.11.1468.

17.

Neurocognitive enhancement therapy with work therapy: effects on neuropsychological test performance.

Bell M, Bryson G, Greig T, Corcoran C, Wexler BE.

Arch Gen Psychiatry. 2001 Aug;58(8):763-8.

PMID:
11483142
18.

Social cognition in psychosis: multidimensional structure, clinical correlates, and relationship with functional outcome.

Mancuso F, Horan WP, Kern RS, Green MF.

Schizophr Res. 2011 Feb;125(2-3):143-51. doi: 10.1016/j.schres.2010.11.007. Epub 2010 Nov 26.

19.

Improving social cognition in schizophrenia: a pilot intervention combining computerized social cognition training with cognitive remediation.

Lindenmayer JP, McGurk SR, Khan A, Kaushik S, Thanju A, Hoffman L, Valdez G, Wance D, Herrmann E.

Schizophr Bull. 2013 May;39(3):507-17. doi: 10.1093/schbul/sbs120. Epub 2012 Nov 3.

20.

Can we incorporate psychosocial treatment interventions into psychopharmacology clinical trials?

Schooler NR.

J Clin Psychiatry. 2012 Jul;73(7):1023-4. doi: 10.4088/JCP.12com07829. No abstract available.

Supplemental Content

Support Center